Exclusive

Publication

Byline

Location

Singapore Clinical Trial: A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adjuvant Chemotherapy Versus Placebo Plus Adjuvant Chemotherapy in Stage IB-IIIA NSCLC Patients with Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)

Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus A... Read More


Singapore Clinical Trial: Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant monotherapy compared with standard of care in patients with early-stage, resectable non-small cell lung cancer (Stage II-IIIB) harboring tyrosine kinase domain activating HER2 mutations

Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvan... Read More


Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the e... Read More


Clinical Trial: Adding Receptive Music to Intradialytic Resistance Exercise in Adults Receiving Maintenance Hemodialysis

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07819331) titled 'Adding Receptive Music to Intradialytic Resistance Exercise in Adults Receiving Maintenanc... Read More


Clinical Trial: Phase II Study of SHR-A1811 for Ultra-Low HER2 Advanced Breast Cancer

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07817082) titled 'Phase II Study of SHR-A1811 for Ultra-Low HER2 Advanced Breast Cancer' on Sept. 08. Brief... Read More


Clinical Trial: Optimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical Evaluation: a Retrospective Study

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07817225) titled 'Optimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical ... Read More


Clinical Trial: Effects of High-Intensity Laser Therapy on Tendon Tissue

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07817368) titled 'Effects of High-Intensity Laser Therapy on Tendon Tissue' on Sept. 03. Brief Summary: Thi... Read More


Clinical Trial: Evaluation of Approved Contact Lenses (CR-6657)

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07819305) titled 'Evaluation of Approved Contact Lenses (CR-6657)' on Sept. 08. Brief Summary: This is a pr... Read More


Clinical Trial: Effects of Diaphragmatic Breathing Exercises on Pain, Grip Strength, and Anthropometric Measures in Women With Chronic Nonspecific Neck Pain

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07816939) titled 'Effects of Diaphragmatic Breathing Exercises on Pain, Grip Strength, and Anthropometric Me... Read More


Clinical Trial: Differentiating True Nephrotoxicity From Pseudo-nephrotoxicity: A Prospective Comparative Study of Vancomycin Plus Piperacillin-Tazobactam vs. Meropenem Using Serum Creatinine and Cystatin-C

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818265) titled 'Differentiating True Nephrotoxicity From Pseudo-nephrotoxicity: A Prospective Comparative ... Read More